Rhetoric is Nice, but Show 'em the Money

The UK government is currently espousing a passion for science. Prime Minister Tony Blair said recently: "The strength and creativity of our science base is a key national asset as we move into the 21st century." And the minister for science and technology, David Sainsbury, recently remarked: "It (science) can improve the quality of our lives by enabling us to live more healthily, and longer". Exactly so. Demonstrating this new attitude, Blair's government has significantly boosted the United

Written byRichard Gallagher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The UK government is currently espousing a passion for science. Prime Minister Tony Blair said recently: "The strength and creativity of our science base is a key national asset as we move into the 21st century." And the minister for science and technology, David Sainsbury, recently remarked: "It (science) can improve the quality of our lives by enabling us to live more healthily, and longer".

Exactly so. Demonstrating this new attitude, Blair's government has significantly boosted the United Kingdom's science budget.1 However, as the salary survey in this issue reveals, not all in the British garden is rosy. One particularly sharp thorn: scientists' meager salaries.

A comparison with American counterparts' incomes makes for depressing reading. In some US cities, an assistant professor, roughly equivalent to a UK lecturer, earns more than a full professor makes in Britain. In Boston, the median entry-level assistant professor salary is $85,000. In London, where ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies